Entera Bio's market cap is currently $83.11M. The company's EPS TTM is $-0.06; its P/E ratio is ―; Entera Bio is scheduled to report earnings on August 8, 2025, and the estimated EPS forecast is $-0.09. See an overview of income statement, balance sheet, and cash flow financials.
